New drug combo aims to beat hard-to-treat bone infections

NCT ID NCT07435051

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a bone-strengthening drug (bisphosphonate) to a standard antibiotic (vancomycin) can better control chronic bone infections that are hard to treat. About 280 adults with a specific type of bone infection will be randomly assigned to get either the combination or the antibiotic alone. The main goal is to see if the infection is under control after 6 months, based on normal temperature, healed wounds, normal blood tests, and new bone growth on X-rays.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOMYELITIS (REFRACTORY) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • the Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310000, China